While millennials and first-time buyers receive a lot of attention in today’s housing market, baby boomers and Gen Xers over ...

With free agency and the 2025 NHL draft all seemingly wrapped up, the Toronto Maple Leafs look to the trade market for their next move. Following a sign-and-trade deal with the Vegas Golden Knights, ...

Enterprise Products Partners is one of the largest midstream businesses in North America. That means that it owns energy ...

Abviax's Obefazimod shows strong potential in ulcerative colitis treatment. Upcoming phase 3 trial data in Q3 2025 is a key ...

President Trump said the crypto industry was once “mocked and dismissed and counted out,” but now could become a big buyer of ...

As earnings season approaches, investors should review their portfolios and assess whether there is still upside left or if ...

These were the most active stocks ahead of Friday's market open: Sarepta Therapeutics Inc.'s stock tumbled 27% after the company said another patient died following gene-therapy treatment, Bloomberg ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

The Nasdaq composite ebbed out of positive territory, down 0.1%. Netflix NFLX was in focus as the stock slumped almost 5%.

The US pharmaceutical industry has undergone notable shifts in recent years, influenced by factors such as the COVID-19 ...

Second-quarter profit jumps 46% at Netflix, while a report says Union Pacific is in early-stage talks to buy smaller railroad rival Norfolk Southern.

It’s a cautious end to the week on Wall Street, as earnings from Netflix Inc. (NASDAQ:NFLX) failed to impress investors.